Gastric Adenocarcinoma: A Multimodal Approach
- PMID: 28824918
- PMCID: PMC5540948
- DOI: 10.3389/fsurg.2017.00042
Gastric Adenocarcinoma: A Multimodal Approach
Abstract
Despite its declining incidence, gastric cancer (GC) remains a leading cause of cancer-related deaths worldwide. A multimodal approach to GC is critical to ensure optimal patient outcomes. Pretherapy fine resolution contrast-enhanced cross-sectional imaging, endoscopic ultrasound and staging laparoscopy play an important role in patients with newly diagnosed ostensibly operable GC to avoid unnecessary non-therapeutic laparotomies. Currently, margin negative gastrectomy and adequate lymphadenectomy performed at high volume hospitals remain the backbone of GC treatment. Importantly, adequate GC surgery should be integrated in the setting of a multimodal treatment approach. Treatment for advanced GC continues to expand with the emergence of additional lines of systemic and targeted therapies.
Keywords: chemotherapy; gastrectomy; gastric adenocarcinoma; gastric cancer; multidisciplinary approach; multimodal therapy; oncology; radiotherapy.
Figures
References
-
- Stewart BW, Wild CP. World Cancer Report 2014. Lyon, France: World Health Organization Press; (2014).
-
- IARC. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. (2015). Available from: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx
-
- NCI. SEER Cancer Statistics Factsheets: Stomach Cancer. (2015). Available from: http://seer.cancer.gov/statfacts/html/stomach.html
-
- Russell MC, Hsu C, Mansfield PF. Primary gastric malignancies. In: Barry W, Feig MD, Denise C, Ching MD, editors. M.D. Anderson Surgical Oncology Handbook. 5th ed Philadelphia, PA: Lippincott Williams & Wilkins; (2012). p. 270–322.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
